Latvia vs Libya: Share of people with HIV who receive antiretroviral therapy
Latvia
52.0%
in 2024
Libya
50.0%
in 2023
Latvia rank
117th
Libya rank
120th
Share of people with HIV who receive antiretroviral therapy over time
- Latvia
- Libya
How they compare
Latvia currently reports 52.0% against 50.0% in Libya, a difference of 2.0%.
The two have swapped places 1 time across 24 shared years of data; in 2000 it was Libya ahead.
Latvia ranks 117th and Libya ranks 120th of 143 countries.
Across the 3 decades both report, Latvia averaged higher in 1 and Libya in 2.
Head to head by decade
| Decade | Latvia | Libya | Difference | Ahead |
|---|---|---|---|---|
| 2000s | 3.2% | 21.1% | 17.9% | Libya |
| 2010s | 22.0% | 55.5% | 33.5% | Libya |
| 2020s | 49.2% | 49.0% | 0.2% | Latvia |
Averages of every year both report within each decade.
Frequently asked questions
- Which has higher share of people with hiv who receive antiretroviral therapy, Latvia or Libya?
- Latvia, at 52.0% against 50.0% in Libya as of 2024.
- What is the difference in share of people with hiv who receive antiretroviral therapy between Latvia and Libya?
- 2.0%, with Latvia ahead.
- How many years of comparable data are there for Latvia and Libya?
- 24 years are reported by both, from 2000 to 2023.
- How do Latvia and Libya rank globally for share of people with hiv who receive antiretroviral therapy?
- Latvia ranks 117th and Libya ranks 120th of 143 countries.
- Where does this data come from?
- UNAIDS estimates, via World Bank (2026) – processed by Our World in Data, published as Share of people with HIV who receive antiretroviral therapy. Statizoid refreshes it automatically from the source and publishes the full history for both places.
Individual pages
About this data
Antiretroviral therapy is a combination of several antiretroviral medicines, used to slow the rate at which HIV multiplies inside the body.